Bain Capital acquires specialty chemicals maker Porus Labs : vimarsana.com

In FY22, Porus posted net sales of ₹806.7 crore, a 19% rise from ₹678.4 crore in FY21. Earnings before interest, taxes, depreciation and amortization (Ebitda) rose 97% to ₹241.6 crore from ₹122.9 crore during the period.

Related Keywords

Canada , India , Cohance Lifesciences , N Purushothama Rao , Srinivasan Namala , Evoqua Water Technologies Corp , Advent International , Xylem Inc , Bain Capital , Sajjan India , Pension Plan Investment Board , Evoqua Water Technologies , Bain , Porus , Brain Capital , Sajjan , Porus Laboratories , Specialty Chemicals Sector , Private Equity Firm , Hyderabad Based ,